About Us

Abingworth is an international investment group dedicated exclusively to the life sciences and healthcare sectors. We invest across all stages of company development including early and late-stage venture financing, growth equity and public companies.

Founded in 1973, Abingworth has a lengthy track record of building market leading companies. Our specialist team of over 20 professionals has a broad range of skills, including scientific and business expertise as well as investment banking, recruitment and legal knowledge. These resources are made available to portfolio companies. Abingworth has funds under management of over $1.25 billion and offices in London, Menlo Park (California) and Boston.

 

Venture Captital Growth Equity Public Markets

 

Edwin Moses, Portfolio Company Chairman and former CEO of Oxford Asymmetry
I am currently working with Abingworth in four of the companies in which they have invested. They are absolutely consistent in their enthusiastic and knowledgeable support and commitment. Most impressively, they have differentiated themselves dramatically from other investors by being able to provide their companies with in-house access to a wide variety of critical specialist expertise in the areas of entrepreneurial management, technical, legal, human resources, M&A and finance. Abingworth is far more than a provider of cash just looking for a return. It is a partner with integrity focused on growing genuine value in developing biotechnology companies.